Ori Spotlight

Por: Ori Biotech
Ori Spotlight covers the latest in cell and gene therapy.

Jason C. Foster, Ori Biotech CEO will be talking to leaders from across the industry to find out more about how we can break down the barriers and seize the opportunities to make sure that every patient has access to life-changing treatments.

Connect with Ori Biotech to learn more about partnering to pioneer innovative technologies in CGT manufacturing that bring CGT products to market at commercial scale at decreased costs while increasing throughput and improving quality: www.oribiotech.com/connect
49 episodios disponibles

Latest episodes of the podcast Ori Spotlight

Warner Biddle: Building a commercial model for CAR-T in autoimmune care 02/09/2025
Lavakumar Karyampudi: Building early-phase CGT infrastructure for translational success 12/08/2025
Henrik Andersen: How smart planning helps CGT scale further, faster 15/07/2025
Arsalan Arif: Investor confidence in advanced therapies is critical for long-term success 01/07/2025
Julie Allickson: How early automation strategies reduce costs and improve patient access 17/06/2025
Aaron Vernon: Designing scalable cell therapy manufacturing from day one (part 2) 03/06/2025
Aaron Vernon: Designing scalable cell therapy manufacturing from day one (part 1) 23/05/2025
Amritha Jaishankar: Advancing data integration and decentralized manufacturing for CGT access 25/11/2024
Boro Dropulić: Simplifying CAR-T workflows will break down barriers to patient access 05/11/2024
Michael Krajewski: How does the Theory of Constraints apply to CGT manufacturing? 08/10/2024
Carl Schoellhammer: viability is the crucial third pillar in CGT 25/06/2024
Anshul Mangal: Unlocking scale, automation, digitalization, and standardization in CGT 04/06/2024
Omkar Kawalekar: technology will unlock scalability and patient access 14/05/2024
Joe DePinto: Bridging growth and accessibility within CGTs 22/04/2024
Matthew Hewitt: scalability is a collective problem 11/03/2024
Adam Siebert & Jeff Holder: early investment in manufacturing is critical for CGT accessibility 19/02/2024
Jim Faulkner: Why unaffordable therapy success is worse than failure... 29/01/2024
Sanjay Srivastava: Are CGTs Developing into a Commercial Dead-End? 08/01/2024
Tim Hunt: leading CGT with education and community 18/07/2023
Vered Caplan: why yesterday’s thinking is not going to solve today’s problems 27/06/2023
1 2 3 Siguiente › Última »
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA